Trial intelligence / Profile preview

Photoallergy Potential of SPF 50 and SPF 15 Sunscreen Formulations

NCT02872220Completed

Sponsor
Bayer
Start
Mar 2015
Primary completion
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of BAY 987519 in sunburn, sponsored by Bayer. Primary endpoints: Evaluation of inflammatory responses up to 3 weeks and Evaluation of superficial effects up to 3 weeks. Started Mar 2015; status: completed.

02

Drugs

BAY 987519
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02872220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02872220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call